Massively parallel signature sequencing and bioinformatics analysis identifies up-regulation of TGFBI and SOX4 in human glioblastoma.
about
Role of SOX family of transcription factors in central nervous system tumorsGene expression profiling of liver cancer stem cells by RNA-sequencingAn integrative approach to the identification of Arabidopsis and rice genes involved in xylan and secondary wall development.The SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysisBiobanks in the United States: how to identify an undefined and rapidly evolving populationMorphometic analysis of TCGA glioblastoma multiforme.LC-MS/MS analysis of differentially expressed glioblastoma membrane proteome reveals altered calcium signaling and other protein groups of regulatory functions.The role of TGFBI in mesothelioma and breast cancer: association with tumor suppression.SOX4 transcriptionally regulates multiple SEMA3/plexin family members and promotes tumor growth in pancreatic cancerSOX4 inhibits GBM cell growth and induces G0/G1 cell cycle arrest through Akt-p53 axisSubtyping glioblastoma by combining miRNA and mRNA expression data using compressed sensing-based approachDifferential expression of ID4 and its association with TP53 mutation, SOX2, SOX4 and OCT-4 expression levels.Evaluation of eight plasma proteins as candidate blood-based biomarkers for malignant gliomas.FoxM1 Drives a Feed-Forward STAT3-Activation Signaling Loop That Promotes the Self-Renewal and Tumorigenicity of Glioblastoma Stem-like Cells.Glioma-initiating cells retain their tumorigenicity through integration of the Sox axis and Oct4 proteinNDRG4 is downregulated in glioblastoma and inhibits cell proliferation.A Meta-Analysis of Retinoblastoma Copy Numbers Refines the List of Possible Driver Genes Involved in Tumor Progression.Transforming growth Factor-Beta-Induced Protein (TGFBI)/(βig-H3): a matrix protein with dual functions in ovarian cancer.The transcriptome and miRNome profiling of glioblastoma tissues and peritumoral regions highlights molecular pathways shared by tumors and surrounding areas and reveals differences between short-term and long-term survivors.Alternative polyadenylation in glioblastoma multiforme and changes in predicted RNA binding protein profilesSpecial AT-rich sequence-binding protein 1 promotes cell growth and metastasis in colorectal cancer.High-mobility group box 2 is associated with prognosis of glioblastoma by promoting cell viability, invasion, and chemotherapeutic resistanceSRM targeted proteomics in search for biomarkers of HCV-induced progression of fibrosis to cirrhosis in HALT-C patients.TMEM2 Is a SOX4-Regulated Gene That Mediates Metastatic Migration and Invasion in Breast CancerNext generation sequencing analysis of miRNAs: MiR-127-3p inhibits glioblastoma proliferation and activates TGF-β signaling by targeting SKI.MicroRNA-564 is downregulated in glioblastoma and inhibited proliferation and invasion of glioblastoma cells by targeting TGF-β1.Functional genomics of the brain: uncovering networks in the CNS using a systems approach.Pleiotropic function of SRY-related HMG box transcription factor 4 in regulation of tumorigenesis.The role of SRY-related HMG box transcription factor 4 (SOX4) in tumorigenesis and metastasis: friend or foe?Molecular cytogenetics: recent developments and applications in cancer.Landscape of the SOX2 protein-protein interactome.SOX4 induces tumor invasion by targeting EMT-related pathway in prostate cancer.Increased expression of SOX4 is associated with colorectal cancer progression.Sox2: regulation of expression and contribution to brain tumors.lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI.ERG-SOX4 interaction promotes epithelial-mesenchymal transition in prostate cancer cells.SOX4 is associated with poor prognosis in prostate cancer and promotes epithelial-mesenchymal transition in vitro.SOX4 is overexpressed in diffusely infiltrating astrocytoma and confers poor prognosis.Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.Proteogenomic characterization and integrative analysis of glioblastoma multiforme.
P2860
Q26860974-3E4DC84C-7D30-440E-85EA-6AB2EE47BF65Q28483663-2EBD497A-AD56-4DA4-8E5B-88AFD6BE63BDQ33760957-C68728EA-8A73-428D-A198-4FE97CC7C993Q33787478-FF124C2A-39DE-4E58-9BD7-3358A16DB6D8Q33828227-B0FC14EE-05C1-4A9C-901D-026702452923Q34107041-0FBF5559-C7A8-4706-AF89-B20D07E266BFQ34118902-F2BF46C7-E049-4B3F-8920-75FE728A1478Q34303247-77202341-6F6F-424C-AD75-4BBB24DF161FQ34515596-69DD9BE2-1FEB-45FD-8B22-88E84DDE15BFQ34517496-F274E95D-ED3D-4B32-9C47-60F3FC5999D0Q34545716-67EC9724-5279-47BF-A41A-1F1DC28A95E6Q34684614-D218437E-01ED-4208-82FD-9DCE37DA52F0Q35067781-BB217DA8-9255-4579-8330-67011248E7EFQ35674906-1761130D-B483-42FE-B0D4-A9BDFEA4F34BQ35842160-9824BD97-3519-4470-890F-D3D3A0D94D4AQ35920078-5647E7F4-D1D8-4E06-A927-7DF34E0B9F87Q35999443-BEB1EA98-60A2-420A-98EA-0594FC6B2CF8Q36202508-7541E8F6-600F-49C6-AEA9-0823F10F4D52Q36356011-485EB566-9010-4327-B4C8-973A6076309FQ36702526-F5D3FF70-0DF9-45CA-987C-24F57DBEF497Q36783174-D4D98A9B-D53C-464B-BBCA-5E3D6562231AQ37109252-AC777054-BE53-419D-A0A5-B565CC7681B1Q37155233-9CBD67B6-24EA-4AE3-BD3F-2E2E8DAACD13Q37415841-1D500380-538F-4826-A047-594AF34E98B5Q37602977-8F341E3B-DD91-471E-9DF5-0B3B3877C7EAQ37636608-327C5AA0-BF22-4D02-9989-D541FEB43B98Q37825465-30FAEDAF-A4EA-45F8-AEC5-6C70FF2B9D83Q38053346-19F51B23-60EA-4A58-979B-A0C57ECDFC8EQ38068040-C4C22618-AE74-401D-B388-476E9447308BQ38119502-C30E3E02-28AC-490F-9CA9-7F514FB89F85Q38503560-E141960F-E937-42D4-B580-6C3687DEAABEQ38705113-3759C1B2-266D-4095-900D-AA0971CBB9F8Q38803591-C9139A5E-3B0D-4F8F-A058-3D57DF47E87EQ38845654-C1511497-0576-4581-ADBE-81C76CC95049Q38978723-86D128AB-2ED8-4F19-9C5B-E3F3057B84BAQ39033577-BF05293B-AC1B-47E2-BB53-50A662B0D684Q39115039-72E51170-580D-4816-8B10-2C8BB3CAC702Q40813966-F63E4A4D-0FF7-45F9-B00E-27DA4C6C6407Q41612074-D5A22940-B259-4CE8-BADF-A0BEC7A526AEQ47099919-46B1EAE6-6141-4091-BC67-133CF6F0F025
P2860
Massively parallel signature sequencing and bioinformatics analysis identifies up-regulation of TGFBI and SOX4 in human glioblastoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Massively parallel signature s ...... nd SOX4 in human glioblastoma.
@ast
Massively parallel signature s ...... nd SOX4 in human glioblastoma.
@en
Massively parallel signature s ...... nd SOX4 in human glioblastoma.
@nl
type
label
Massively parallel signature s ...... nd SOX4 in human glioblastoma.
@ast
Massively parallel signature s ...... nd SOX4 in human glioblastoma.
@en
Massively parallel signature s ...... nd SOX4 in human glioblastoma.
@nl
prefLabel
Massively parallel signature s ...... nd SOX4 in human glioblastoma.
@ast
Massively parallel signature s ...... nd SOX4 in human glioblastoma.
@en
Massively parallel signature s ...... nd SOX4 in human glioblastoma.
@nl
P2093
P2860
P1433
P1476
Massively parallel signature s ...... nd SOX4 in human glioblastoma.
@en
P2093
Anup Madan
Biaoyang Lin
Daehee Hwang
Gregory Foltz
Jae-Geun Yoon
Taek-Kyun Kim
Xiaowei Yan
Xuefeng Fang
P2860
P304
P356
10.1371/JOURNAL.PONE.0010210
P407
P50
P577
2010-04-19T00:00:00Z